Navigation Links
India's anti-AIDS drug market engaged in price war

The Indian pharmaceutical companies hope to strike a pot of gold by making cheap anti-AIDS drugs. This has triggered a price war that is likely to escalate in coming days.

The large number of AIDS cases has lured many companies to develop anti-AIDS drugs and market it in India and abroad by adapting innovative approaches to pricing.

The anti-AIDS drug market, currently dominated by Mumbai-based Cipla, witnessed the entry of four more pharmaceutical companies including Ranbaxy laboratories, GlaxoSmithKline Pharmaceuticals, Aurobindo Pharmaceuticals and Zydus Cadila in a short span of six months to one year.

The rising competition in the domestic anti-AIDS drug market has led to Cipla, a leader in the segment, cut its brand prices five to six times in the last three years. Thus, Cipla triggered a controversy by offering anti-AIDS drugs at a drastically lower prices.

Pharmaceutical companies in India are able to gain good healthy revenues, even if these anti-AIDS drugs are sold at steep discounts. India's patent laws currently protect only the processes by which drugs are made but not the products themselves.
'"/>




Page: 1

Related medicine news :

1. SARS: Indias drugs in demand
2. Indias Hospitals Among The Best, Says Renuka Chowdhury
3. Indias vaccination project gets a boost
4. WHO Commends Indias Bird Flu Response
5. Minister Of State For Industry Urges Corporate Sectors To Help Indias Disabled Population
6. Indias Economic Boom Pack To Waste Children Life
7. Indias Northeast Students to Get Satellite-based Education Soon
8. Norway Grants $80 mn to Indias Health Mission
9. Pakistani Child is Indias Youngest Liver Transplant Recipient
10. Avian flu-free Status to Boost Indias Poultry Exports
11. Britains Support for Indias Health Programme
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/28/2017)... ... April 28, 2017 , ... ... integration of Microsoft(R) Word(TM) Online(TM), which enables sleep physicians to create and edit ... the reporting process and provides a familiar interface that does not require additional ...
(Date:4/28/2017)... ... , ... Getting enough sleep affects much more than energy – it also has mental and ... can compromise motor reaction time, which can increase the risk of having a car accident. ... tips from the NSF to help you sleep better and feel better:, ...
(Date:4/28/2017)... Cypress, California (PRWEB) , ... April 28, 2017 ... ... LED T8 Direct Replace tubes . These lamps offer an instant energy-saving solution ... no need to rewire fixtures or disconnect ballasts. These 50,000 hour rated lamps ...
(Date:4/28/2017)... ... April 28, 2017 , ... Children and adolescents who ... experiences than children in the general population. That’s because foster care is designed ... family challenges. While no fault of their own, youth who have experienced trauma ...
(Date:4/28/2017)... ... 28, 2017 , ... Early detection and elimination of new ... minimize the cost of development. In this webinar, sponsored by Molecular Devices, an ... for cardiac toxicity using induced pluripotent stem cells (iPSCs). , In the first ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... , April 20, 2017 ... "Global Biosimilar Pipeline and Market Prospects: Addressing Production ... report to their offering. ... "Global Biosimilar Pipeline and Market Prospects: ... Design" provides an in-depth assessment of the current trends ...
(Date:4/20/2017)... 2017  CVS Pharmacy, the retail division of ... store design to enhance the retail customer experience ... products and expanded beauty selections paired with informational ... new offerings. Together with its innovative digital programs, ... customer experience at CVS Pharmacy.  ...
(Date:4/20/2017)... 20, 2017 Research and Markets has ... Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, ... their offering. ... pharmacogenomics market was valued at US$ 7,167.6 Mn in 2015, ... expanding at a CAGR of 5.6% from 2016 to 2024. ...
Breaking Medicine Technology: